FOLH1 and prostate carcinoma: Having in mind that a single compound treatment using Duta or Lova significantly induces PSMA expression in different prostate cancer cells, we further explored the following question: is a combination treatment using lower concentrations of Duta and Lova capable of further increasing PSMA upregulation compared to a single compound treatment?